Prevention and repair of protein damage by the Maillard reaction in vivo
- PMID: 16706654
- DOI: 10.1089/rej.2006.9.264
Prevention and repair of protein damage by the Maillard reaction in vivo
Abstract
The aging human extracellular matrix (ECM) and tissues rich in long-lived proteins undergo extensive changes with age that include increased stiffening, loss of elasticity, insolubilization, and decreased proteolytic digestibility. Most if not all these changes can be duplicated by the Maillard reaction in vitro, that is, the incubation of the proteins with reducing sugars and oxoaldehydes. These carbonyls eventually form advanced glycation end products (AGEs) and crosslinks that impair proteolytic digestibility and alter protein conformation. To date, close to 20 AGEs have been found in the human skin, of which ornithine is the single major result of damage to arginine residues, and glucosepane the single major crosslink. Although redox active metals and oxoaldehydes appear to play an important role in protein damage in experimental diabetes, their role in diabetic humans is still poorly understood. Evidence for the existence of deglycating enzymes has been found in vertebrates, bacteria, and fungi. However, only the vertebrate enzymes can deglycate larger, intracellular proteins via an ATP-dependent mechanism. Protein engineering will thus be needed to adapt Amadoriase enzymes toward deglycation of ECM proteins for purpose of probing the role of advanced glycation in animal models of diabetes and age-related diseases. The blocking of the reactivity of the glucosepane precursor using potent nucleophiles may be useful in preventing age-related changes in ECM proteins. However, there currently is no evidence in support of the proposed ability of so-called "AGE breakers" to cleave existing crosslinks of the Maillard reaction in vivo, and other mechanisms of action should be sought for this class of compounds.
Similar articles
-
Age-related accumulation of Maillard reaction products in human articular cartilage collagen.Biochem J. 2000 Sep 1;350 Pt 2(Pt 2):381-7. Biochem J. 2000. PMID: 10947951 Free PMC article.
-
Cross-linking of the extracellular matrix by the maillard reaction in aging and diabetes: an update on "a puzzle nearing resolution".Ann N Y Acad Sci. 2005 Jun;1043:533-44. doi: 10.1196/annals.1333.061. Ann N Y Acad Sci. 2005. PMID: 16037276 Review.
-
The role of the amadori product in the complications of diabetes.Ann N Y Acad Sci. 2008 Apr;1126:81-8. doi: 10.1196/annals.1433.052. Ann N Y Acad Sci. 2008. PMID: 18448799
-
The Maillard reaction in the human body. The main discoveries and factors that affect glycation.Pathol Biol (Paris). 2010 Jun;58(3):214-9. doi: 10.1016/j.patbio.2009.09.014. Epub 2009 Nov 6. Pathol Biol (Paris). 2010. PMID: 19896783 Review.
-
Extracellular glycation crosslinks: prospects for removal.Rejuvenation Res. 2006 Summer;9(2):274-8. doi: 10.1089/rej.2006.9.274. Rejuvenation Res. 2006. PMID: 16706655
Cited by
-
Therapeutic potential of copper chelation with triethylenetetramine in managing diabetes mellitus and Alzheimer's disease.Drugs. 2011 Jul 9;71(10):1281-320. doi: 10.2165/11591370-000000000-00000. Drugs. 2011. PMID: 21770477 Review.
-
Modulation of advanced glycation endproduct synthesis by kynurenines in human lens proteins.Biochim Biophys Acta. 2010 Apr;1804(4):829-38. doi: 10.1016/j.bbapap.2009.12.008. Epub 2009 Dec 22. Biochim Biophys Acta. 2010. PMID: 20026434 Free PMC article.
-
Plasma advanced glycation end products and the subsequent risk of microvascular complications in type 1 diabetes in the DCCT/EDIC.BMJ Open Diabetes Res Care. 2022 Jan;10(1):e002667. doi: 10.1136/bmjdrc-2021-002667. BMJ Open Diabetes Res Care. 2022. PMID: 35058313 Free PMC article.
-
Succination of thiol groups in adipose tissue proteins in diabetes: succination inhibits polymerization and secretion of adiponectin.J Biol Chem. 2009 Sep 18;284(38):25772-81. doi: 10.1074/jbc.M109.019257. Epub 2009 Jul 10. J Biol Chem. 2009. PMID: 19592500 Free PMC article.
-
Pharmacological control of receptor of advanced glycation end-products and its biological effects in psoriasis.Int J Biomed Sci. 2013 Sep;9(3):112-22. Int J Biomed Sci. 2013. PMID: 24170986 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources